Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-15 Sale | 2026-09-17 9:35 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 209,048 | $62.83 | $13,135,397 | 98,547 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 9:35 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 283,189 | $63.06 | $17,857,830 | 262,213 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 9:33 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula EVP, Head of R&D & CMO | 44,674 | $62.34 | $2,785,021 | 144,096 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 9:32 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 37,500 | $62.34 | $2,337,695 | 105,389 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 9:31 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 400,000 | $63.48 | $25,390,729 | 845,713 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 9:30 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 50,508 | $62.34 | $3,148,544 | 87,508 (Direct) | View |
| 2026-09-15 Sale | 2026-09-17 9:29 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 5,375 | $62.33 | $335,005 | 63,978 (Direct) | View |
| 2026-09-10 Sale | 2026-09-11 4:05 pm | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 20,000 | $67.31 | $1,346,106 | 91,500 (Direct) | View |
| 2026-09-02 Sale | 2026-09-03 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 642 | $66.37 | $42,610 | 118,016 (Direct) | View |
| 2026-08-17 Sale | 2026-08-19 4:05 pm | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 10,000 | $63.28 | $632,846 | 66,500 (Direct) | View |
| 2026-06-12 Sale | 2026-06-16 4:46 pm | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 10,000 | $50.07 | $500,747 | 56,250 (Direct) | View |
| 2026-06-12 Sale | 2026-06-16 4:42 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $50 | $225,000 | 41,500 (Direct) | View |
| 2026-05-15 Sale | 2026-05-19 4:05 pm | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 3,250 | $43.49 | $141,343 | 52,250 (Direct) | View |
| 2026-05-05 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $46.65 | $209,925 | 37,500 (Direct) | View |
| 2026-05-04 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 8,000 | $45 | $360,000 | 87,500 (Direct) | View |
| 2026-05-06 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 2,763 | $43.95 | $121,434 | 128,224 (Direct) | View |
| 2026-05-04 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 24,250 | $45.06 | $1,092,657 | 117,961 (Direct) | View |
| 2026-05-04 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 22,485 | $45.15 | $1,015,086 | 160,488 (Direct) | View |
| 2026-05-05 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 2,174 | $46.65 | $101,417 | 153,434 (Direct) | View |
| 2026-05-06 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 22,500 | $43.95 | $988,875 | 500,386 (Direct) | View |
| 2026-05-05 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 2,491 | $46.31 | $115,368 | 131,408 (Direct) | View |
| 2026-05-01 Sale | 2026-05-04 4:27 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,750 | $44.22 | $431,145 | 47,250 (Direct) | View |
| 2026-04-22 Sale | 2026-04-23 4:05 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 9,100 | $39.09 | $355,719 | 113,987 (Direct) | View |
| 2026-04-14 Sale | 2026-04-16 4:05 pm | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 8,000 | $41.07 | $328,560 | 57,500 (Direct) | View |
| 2026-04-14 Sale | 2026-04-16 4:05 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 32,750 | $41.29 | $1,352,130 | 53,250 (Direct) | View |
| 2026-04-14 Sale | 2026-04-16 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 21,977 | $41.07 | $902,595 | 79,353 (Direct) | View |
| 2026-04-14 Sale | 2026-04-15 9:49 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 7,215 | $41.93 | $302,516 | 138,608 (Direct) | View |
| 2026-04-15 Sale | 2026-04-15 9:48 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 64,000 | $41.09 | $2,629,975 | 432,886 (Direct) | View |
| 2026-04-14 Sale | 2026-04-15 9:47 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 51,500 | $41.29 | $2,126,452 | 162,711 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-16 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 57,500 | $26.88 | 98,547 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 39,000 | $25.25 | 98,547 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 40,000 | $17.96 | 98,547 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A 2028-05-10 | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 191,500 | $0 | 98,547 (Direct) | View |
| 2026-09-16 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 55,000 | $15.46 | 98,547 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 57,000 | $26.88 | 262,213 (Direct) | View |
| 2026-09-16 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 100,000 | $11.25 | 262,213 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 9,663 | $22.4 | 262,213 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A 2031-01-21 | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 258,189 | $0 | 262,213 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 36,526 | $8.93 | 262,213 (Direct) | View |
| 2026-09-16 Exercise | 2026-09-17 9:35 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 55,000 | $15.46 | 262,213 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:33 pm | N/A 2034-01-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula EVP, Head of R&D & CMO | 32,395 | $0 | 144,096 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:33 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula EVP, Head of R&D & CMO | 32,395 | $8.93 | 144,096 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:32 pm | N/A 2030-01-31 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 37,500 | $0 | 105,389 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:32 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 37,500 | $15.46 | 105,389 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:31 pm | N/A 2029-01-04 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 400,000 | $0 | 845,713 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:31 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 400,000 | $23.34 | 845,713 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:30 pm | N/A 2027-05-17 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 20,000 | $0 | 87,508 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:30 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 20,000 | $17.44 | 87,508 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:29 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 1,250 | $22.4 | 63,978 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:29 pm | N/A 2032-01-31 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 5,375 | $0 | 63,978 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:29 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 1,625 | $20.46 | 63,978 (Direct) | View |
| 2026-09-15 Exercise | 2026-09-17 9:29 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 2,500 | $27.5 | 63,978 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-11 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 10,000 | $26.52 | 91,500 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-11 4:05 pm | N/A 2027-05-17 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 20,000 | $0 | 91,500 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-11 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 10,000 | $17.44 | 91,500 (Direct) | View |
| 2026-08-17 Exercise | 2026-08-19 4:05 pm | N/A 2027-05-17 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 10,000 | $0 | 66,500 (Direct) | View |
| 2026-08-17 Exercise | 2026-08-19 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 10,000 | $17.44 | 66,500 (Direct) | View |
| 2026-06-22 Gift | 2026-06-22 4:37 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 468 | $0 | 112,770 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:46 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 10,000 | $26.52 | 56,250 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:46 pm | N/A 2028-05-08 | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 10,000 | $0 | 56,250 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:42 pm | N/A 2032-05-11 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $0 | 41,500 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:42 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $21.38 | 41,500 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director | 16,000 | $0 | 41,750 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Squarer Ron Director | 16,000 | $0 | 51,375 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Poole Sandra Director | 16,000 | $0 | 46,000 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 16,000 | $0 | 51,375 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 16,000 | $0 | 103,500 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 16,000 | $0 | 73,500 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 16,000 | $0 | 68,250 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director | 16,000 | $0 | 44,750 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $0 | 53,500 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $18.27 | 37,500 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-06 8:00 pm | N/A 2031-05-14 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $0 | 37,500 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 8,000 | $16.33 | 87,500 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A 2026-05-18 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 8,000 | $0 | 87,500 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 4,250 | $0 | 128,224 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 8,500 | $0 | 128,224 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 20,000 | $17.96 | 117,961 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A 2029-05-09 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 24,250 | $0 | 117,961 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 8,500 | $0 | 117,961 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 20,000 | $22.4 | 160,488 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A 2033-01-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 24,250 | $0 | 160,488 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 8,500 | $0 | 160,488 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 4,250 | $0 | 153,434 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 8,500 | $0 | 153,434 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 22,500 | $0 | 500,386 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 45,000 | $0 | 500,386 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 4,250 | $0 | 131,408 (Direct) | View |
| 2026-05-04 Option Award | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 8,500 | $0 | 131,408 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 4:27 pm | N/A 2034-05-08 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,750 | $0 | 47,250 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 4:27 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,750 | $6.82 | 47,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 8,000 | $16.33 | 57,500 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A 2026-05-18 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 8,000 | $0 | 57,500 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,000 | $15.43 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $18.27 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 8,000 | $17.94 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A 2029-05-08 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 32,750 | $0 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $21.38 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 6,750 | $17.11 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 2,500 | $22.4 | 79,353 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A 2033-01-31 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,250 | $0 | 79,353 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 6,250 | $8.93 | 79,353 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 6,500 | $20.46 | 79,353 (Direct) | View |
| 2026-04-13 Option Award | 2026-04-15 9:49 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 14,000 | $0 | 138,608 (Direct) | View |
| 2026-04-13 Option Award | 2026-04-15 9:48 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 14,000 | $0 | 123,087 (Direct) | View |
| 2026-04-13 Option Award | 2026-04-15 9:48 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 64,000 | $0 | 432,886 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-15 9:47 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $19.08 | 162,711 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-15 9:47 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 20,000 | $17.96 | 162,711 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-15 9:47 pm | N/A 2030-01-31 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 37,500 | $0 | 162,711 (Direct) | View |
| 2026-04-13 Option Award | 2026-04-15 9:47 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 14,000 | $0 | 162,711 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-15 9:47 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 7,500 | $15.46 | 162,711 (Direct) | View |